Opinions are my own & do not rep NIA/NIH/HHS
Joined March 2018
- Tweets 408
- Following 162
- Followers 929
- Likes 627
33 Photos and videos
Andrew retweeted
9 Aug 2023
Great opportunity!!! @interneurona could you share it between your #LATAM colleagues???
📢 Reminder! The application window to apply for trainee funding through GP2's Underrepresented Populations PhD Program closes 8/31. If you identify as a supervisor from an underrepresented group, apply today pulse.ly/bzgbq5dpcd
1
6
1,747
20 May 2023
Kimberley has done an amazing job standing up high throughput long read sequencing at CARD….
19 May 2023
Today we heard from Kimberley on utilising long nanopore reads to sequence ~4,000 human brain clinical research samples, to further understand Alzheimer’s disease and related dementias #nanoporeconf
8
1,972
19 May 2023
love this collaboration!
18 May 2023
Our own @C_WSolsberg @halsty and friends from NIH CARD 🧬 identify novel AD loci by leveraging diversity across populations @UCSFmac
1
1
6
1,942
Andrew retweeted
18 May 2023
Been a great day for publications from the team. @mkoretsky1 and the team great job on showing genetic overlap and in some instances a depletion of genetic risk across and within neurodegenerative diseases.
18 May 2023
Genetic risk factor clustering within and across neurodegenerative conditions (such as #Parkinsons, #Alzheimers, #ALS) - from @HamptonLLeonard & colleagues; "Neurodegenerative diseases have more overlapping genetic etiology than previously expected"
academic.oup.com/brain/advan…
1
6
13
3,017
Andrew retweeted
10 May 2023
Dramatic improvement for @nanopore DRS using kits RNA004 vs RNA002 @NUBioE1
a) Human poly-A RNA alignment identity: 2019 (RNA002, 86%), 2022 (RNA002, 89.8%), 2023 (RNA004, 95.6%)
b) Human MT poly-A RNA read alignments (2019 vs 2023). Colored lines = base mismatches
@AkesonUCSC
6
34
104
17,821
Andrew retweeted
28 Apr 2023
Pssst, next GP2 release in ~2 weeks 🤐.
Release 5 for Cinco de Mayo (well a few days after).
3
7
1,004
Andrew retweeted
14 Apr 2023
41 novel targets, network insights and potential tox inferences ... #opensource #openscience ... app here nih-card-ndd-smr-home-syboky….
Awesome work from Chelsea X. A. (sensibly twitter averse) to leverage public resource to do this (thx @OpenTargets and other for the APIs)!
2
6
712
Andrew retweeted
14 Apr 2023
New preprint from the team at CARD, nominating novel drug targets for neurodegenerative disease using multi-omic and genetic data.
Hoping this is a starting point for community target discovery specifically focused on ADRD.
medrxiv.org/content/10.1101/…
1
17
43
8,057
Andrew retweeted
Funding opportunity! GP2 is co-funding two places for @movedisorder Aspen Course. If you are an early career Movement Disorders Fellow who identifies as belonging to an underrepresented group in #PD research, we encourage you to apply. Deadline is 5/1: pulse.ly/4uqz6ymutl
2
1
705
Andrew retweeted
10 Mar 2023
Great presentation of @mario_cornejo_o in #IIIcongressobrasileironeurogenetica @LARGE_PD @ASAP_Research @arturschuh @nachogenePD
1
4
13
970
Andrew retweeted
7 Mar 2023
I wrote a blog post for International Women's Day, featuring women in #datascience and #neuroscience at @NIHAging's Center for #Alzheimers and related dementias!
card.nih.gov/news-events/car…
#scicomm #InternationalWomensDay
5
15
5,266
Andrew retweeted
🎉In case you missed it📢
BLAAC-PD is expanding to six sites, allowing the initiative to continue to grow its partnerships with traditionally underrepresented populations and helping to unlock the genetic architecture of #ParkinsonsDisease. michaeljfox.org/publication/…
1
4
430
Andrew retweeted
If you are a doctor or scientist based in Africa, Asia or Latin America interested in getting a master's in clinical neurology or data science via distance learning @ucl or @UMBC, apply for GP2 support! Learn more: gp2.org/opportunities/?utm_s…
1
10
11
1,705
13 Feb 2023
V Excited about this....Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD biorxiv.org/content/10.1101/…
1
3
808
Andrew retweeted
6 Jan 2023
📢 Apply to get trained in data science while working with a ton of talented and motivated scientists on Alzheimer’s and related dementias research at #CARD ! 📢 🤩
The @NIH Center for Alzheimer’s and Related Dementias (CARD) Master’s Program application portal is now open! Interested in pursuing a master’s degree from @UMBC and a career in #DataScience? Apply by May 1: tinyurl.com/3xssv6c9 #CARDMastersProgram
1
4
684
30 Nov 2022
A nice thread here:
30 Nov 2022
BREAKING NEWS: New #Alzheimer drug #Lecanemab slows cognitive decline (18-month change in CDR-SB) by 27%, drastically lowers brain amyloid load by 59 centiloids to 23 (below PET amyloid positivity)! NEJM paper: nejm.org/doi/full/10.1056/NE… prnewswire.com/news-releases… #CTAD
2
7
19 Nov 2022
It’s quafftide somewhere. Here in fact.
18 Nov 2022
Word of the day is ‘quafftide’(16th century): a one-word announcement that it’s time for a drink.
2
Andrew retweeted
18 Nov 2022
gp2.org/the-components-of-gp…
@ASAP_Research says GP2 release 3 is now official.
Shout outs to the team for sharing > 14K samples!
Nice work in particular from @HamptonLLeonard @KristinSLevine @mbmakarious #DanV and #MatK on the blog post and README.
READMEs, always important 🧐.
1
6
13
9 Nov 2022
a fantastic resource....really excited to support this work through CARD at the NIH IRP. Next comes the exciting part...
8 Nov 2022
New batch of engineered iPSC lines from JAX/iNDI, including much-requested APOE variants! Isogenic sets of APOE2, 3, 4, and Christchurch variants, plus revertant controls, all deeply QC'd and available with a clickable online MTA. jax.org/jax-mice-and-service…
4
Andrew retweeted
2 Nov 2022
Anyone dug around in their GP2 tier2 buckets lately? If so, how's new data in release 3 (its live already in your workspace 😈).
R3 is official very soon (couple weeks), keep your eyes on the GP2 blog.
Epic teamwork from too many (some on this call)!
#OpenScience
1
4
10